Novo Nordisk Drops $11 Billion to Expand Weight-Loss Drug Production
It’s bulking season at Novo Nordisk. On Monday, the Danish pharma firm behind Wegovy and Ozempic announced an $11 billion deal to significantly expand production capacity for its blockbuster weight-loss drugs. The Weighting Game The massive success of both drugs almost instantly made Novo Nordisk…
#novonordisk #danish #wegovyandozempic #weightinggame #novo #novoholdings #novonordisks #catalent #belgium #indiana
